Journals / Experimed / 2020 / Cilt: 10 - Sayı: 3

Betulinic Acid and its Anticancer Effects

Betülinik Asit ve Antikanser Etkiler

Journal
Experimed
Pages
128–134
Publication Date
2020-12-24
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In addition, the fact that betulinic acid directly affects cancer cells and has no toxic effect on healthy cells makes it a potential anticancer molecule in developing chemotherapy strategies.This review aims to discuss the structural and biological properties of betulinic acid and the anticancer effects in various cancer types.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In recent years, interest in naturally occurring compounds in plants has been increasing.
📊
Key Findings & Data:Due to the benefits of these compounds, various studies have been carried out for their therapeutic use in cancer treatment as well as in daily use.
💡
Conclusion & Impact:In addition, the fact that betulinic acid directly affects cancer cells and has no toxic effect on healthy cells makes it a potential anticancer molecule in developing chemotherapy strategies.This review aims to discuss the structural and biological properties of betulinic acid and the anticancer effects in various cancer types.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Betülinik asit · kanser · apoptoz

Abstract

In recent years, interest in naturally occurring compounds in plants has been increasing. Due to the benefits of these compounds, various studies have been carried out for their therapeutic use in cancer treatment as well as in daily use. These studies have aimed to develop chemotherapeutics that are natural and can stimulate apoptosis due to the side effects of chemotherapeutics used in current cancer treatments. One of these compounds, betulinic acid, is lupane-type pentacyclic triterpenoid, a secondary metab-olite found in the bark of various trees. Betulinic acid has strong anticancer properties as well as antiviral and anti-inflammatory effects. It performs its anticancer functions by promoting the mi-tochondrial apoptosis, regulating cell cycle and angiogenesis, and activating or deactivating many pathways which are important for cancer development. Molecules that directly affect mitochondria such as betulinic acid, hold great promise in preventing drug re-sistance that may occur in the treatment process. In addition, the fact that betulinic acid directly affects cancer cells and has no toxic effect on healthy cells makes it a potential anticancer molecule in developing chemotherapy strategies.This review aims to discuss the structural and biological properties of betulinic acid and the anticancer effects in various cancer types.

Özet

Son yıllarda, bitkilerin yapısında doğal olarak bulunan bileşiklere duyulan ilgi giderek artmaktadır. Bu bileşiklerin sağladıkları fay-dalar nedeniyle günlük kullanımın yanı sıra kanser tedavisinde terapötik olarak kullanılmasına yönelik çeşitli çalışmalar yapılmak-tadır. Bu çalışmalar, güncel kanser tedavilerinde kullanılan kemo-terapötiklerin ortaya çıkardığı yan etkiler nedeniyle doğal kaynaklı ve apoptozu uyarabilen kemoterapötiklerin geliştirilmesini amaç-lamaktadır. Bu bileşiklerden biri olan betülinik asit, lupan tipi pen-tasiklik triterpenoid olup çeşitli ağaçların kabuklarında bulunan bir sekonder metabolittir. Betülinik asit, antiviral ve antiinflamatuvar etkiler gibi biyolojik aktivitelerin yanı sıra güçlü bir antikanser ak-tiviteye sahiptir. Bu antikanser aktivitesini, mitokondriyal apopto-zu teşvik ederek, hücre siklusunu ve anjiyogenezi düzenleyerek ve kanser gelişimi için önemli birçok yolağı aktive veya inaktive ederek gerçekleştirir. Betülinik asit gibi doğrudan mitokondriyi et-kileyen moleküller, tedavi sürecinde oluşabilecek ilaç direncini en-gellemek için büyük umut vaad etmektedir. Ayrıca betülinik asidin kanser hücrelerini doğrudan etkileyip sağlıklı hücrelere karşı toksik etkisinin olmaması geliştirilmekte olan kemoterapi stratejilerinde onu potansiyel antikanser molekül haline getirmektedir. Bu derlemede, betülinik asidin yapısal ve biyolojik özellikleri ile çeşitli kanser türlerindeki antikanser etkilerinin tartışılması amaç-lanmaktadır.

🔖

Cite This Article

ATAŞ, M. N., ERGEN, A. (2020). Betulinic Acid and its Anticancer Effects. Experimed, Cilt: 10 - Sayı: 3, 128–134. https://ajindex.com/articles/83701

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Glo-bal cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018
  2. [CrossRef ] 2. de Castro Sant' Anna C, Junior AGF, Soares P, Tuji F, Paschoal E, Chaves LC, et al. Molecular biology as a tool for the treatment of cancer. Clin Exp Med 2018
  3. [CrossRef ] 3. Francia R, Monaco A, Saggese M, Iaccarino G, Crisci S, Frigeri F, et al. Pharmacological profile and Pharmacogenomics of anti-cancer drugs used for targeted therapy. Curr Cancer Drug Targets 2018
  4. 18(5): 499-511. 4. Lichota A, Gwozdzinski K. Anticancer activity of natural compoun-ds from plant and marine environment. Int J Mol Sci 2018
  5. 19(11): 3533. [CrossRef ] 5. Delgoda R, Murray JE. Evolutionary Perspectives on the Role of Plant Secondary Metabolites. In: Badal S, Delgoda R, editors. Phar-macognosy, Academic Press, 2017. p. 93-100. [CrossRef ] 6. Kabera JN, Semana E, Mussa AR, He X. Plant Secondary Metabo-lites: Biosynthesis, Classification, Function and Pharmacological Properties. J Pharm Pharmacol 2014
  6. Tholl D. Biosynthesis and biological functions of terpenoids in plants. Adv Biochem Eng Biotechnol 2015
  7. [CrossRef ] 8. Zhang X, Hu J, Chen Y. Betulinic acid and the pharmacological effects of tumor suppression. Mol Med Rep 2016
  8. [CrossRef ] 9. Csuk R. Betulinic acid and its derivatives: A patent review (2008-2013). Expert Opin Ther Pat 2014
  9. [CrossRef ] 10. Kumar P, Bhadauria AS, Singh AK, Saha S. Betulinic acid as apopto-sis activator: Molecular mechanisms, mathematical modeling and chemical modifications. Life Sci 2018
  10. [CrossRef ] 11. Fulda S, Kroemer G. Targeting mitochondrial apoptosis by betu-linic acid in human cancers. Drug Discov Today 2009
  11. [CrossRef ] 12. Cháirez-Ramírez M, Moreno-Jiménez M, González-Laredo R, Galle-gos-Infante J, Rocha-Guzmán N. Lupane-type triterpenes and the-ir anti-cancer activities against most common malignant tumors: A review. EXCLI J 2016
  12. Ríos J, Máñez S. New Pharmacological Opportunities for Betulinic Acid. Planta Med 2018
  13. [CrossRef ] 14. An T, Zha W, Zi J. Biotechnological production of betulinic acid and derivatives and their applications. Appl Microbiol Biotechnol 2020
  14. [CrossRef ] 15. Hordyjewska A, Ostapiuk A, Horecka A, Kurzepa J. Betulin and be-tulinic acid: triterpenoids